Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more
Procept Biorobotics Corp (PRCT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.017x
Based on the latest financial reports, Procept Biorobotics Corp (PRCT) has a cash flow conversion efficiency ratio of -0.017x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.63 Million) by net assets ($380.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Procept Biorobotics Corp - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Procept Biorobotics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Procept Biorobotics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Exail Technologies S.A.
PA:EXA
|
0.102x |
|
ASCENTAGE PHARM. DL-0001
F:36X
|
N/A |
|
Intapp Inc
NASDAQ:INTA
|
0.028x |
|
LIVZON PHARMAC. GRP H YC1
F:LP6
|
N/A |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
0.056x |
|
By health
SHE:300146
|
0.025x |
|
Arcplus Group PLC
SHG:600629
|
0.035x |
|
Eternal Materials Co Ltd
TW:1717
|
0.042x |
Annual Cash Flow Conversion Efficiency for Procept Biorobotics Corp (2019–2024)
The table below shows the annual cash flow conversion efficiency of Procept Biorobotics Corp from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $402.22 Million | $-99.21 Million | -0.247x | +35.88% |
| 2023-12-31 | $280.75 Million | $-108.00 Million | -0.385x | +5.69% |
| 2022-12-31 | $197.07 Million | $-80.38 Million | -0.408x | -90.01% |
| 2021-12-31 | $267.09 Million | $-57.33 Million | -0.215x | +72.93% |
| 2020-12-31 | $60.96 Million | $-48.34 Million | -0.793x | +47.10% |
| 2019-12-31 | $29.23 Million | $-43.82 Million | -1.499x | -- |